Open Access
CC BY 4.0 · Endosc Int Open 2026; 14: a27816649
DOI: 10.1055/a-2781-6649
Original article

Characteristics and causes of post-endoscopy Barrett’s neoplasia: Retrospective multicenter study

Authors

  • Satoko Kako

    1   Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan (Ringgold ID: RIN34808)
  • Yugo Iwaya

    1   Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan (Ringgold ID: RIN34808)
  • Atsuhiro Hirayama

    1   Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan (Ringgold ID: RIN34808)
  • Takuma Okamura

    1   Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan (Ringgold ID: RIN34808)
  • Norikazu Arakura

    2   Department of Gastroenterology, Aizawa Hospital, Matsumoto, Japan (Ringgold ID: RIN73464)
  • Tomoaki Suga

    3   Department of Gastroenterology, Suwa Red Cross Hospital, Suwa, Japan (Ringgold ID: RIN26863)
  • Takayuki Watanabe

    4   Department of Gastroenterology, Iiyama Red Cross Hospital, Iiyama, Japan (Ringgold ID: RIN73703)
  • Akihiro Ito

    5   Department of Gastroenterology, Matsumoto City Hospital, Matsumoto, Japan (Ringgold ID: RIN631885)
  • Daichi Hara

    6   Department of Gastroenterology, Nagano Municipal Hospital, Nagano, Japan (Ringgold ID: RIN13682)
  • Tadanobu Nagaya

    7   Endoscopic Examination Center, Shinshu University Hospital, Matsumoto, Japan (Ringgold ID: RIN118108)

Abstract

Background and study aims

Missed high-grade dysplasia (HGD) or adenocarcinoma in Barrett's esophagus (BE) may have serious consequences, although the attributes of post-endoscopy Barrett's neoplasia (PEBN) remain unexplored. We analyzed the characteristics of Barrett’s neoplasia (BN) eluding detection during screening endoscopy.

Methods

We retrospectively reviewed endoscopic images of BN, including HGD and adenocarcinoma, diagnosed at six centers in Nagano prefecture. Eligible patients had index endoscopic images obtained 7 to 36 months before BN diagnosis. Causes of PEBN were classified as perceptual error, in which BN was missed despite images taken where it was eventually diagnosed, or exposure error, whereby no images were obtained in the area of BN development.

Results

Among the 91 patients with BN, 31 were judged as having PEBN. The majority of PEBN cases were attributed to perceptual error (22 patients, 71%). Lesions within long-segment BE (LSBE) were significantly more likely to be overlooked due to exposure error (67% vs. 18%, P = 0.02), whereas lesions at the 0 to 3 o’clock position in short-segment BE (SSBE) tended to be missed due to perceptual error (76% vs. 33%, P = 0.04). Notably, 39% of perceptual error cases were misdiagnosed as esophagitis on index endoscopy. In the nine patients requiring surgery for PEBN, eight cases were attributed to perceptual error.

Conclusions

PEBN occurring in LSBE was mostly overlooked because of inadequate observation, whereas PEBN at the 0 to 3 o'clock position in SSBE was frequently misdiagnosed as esophagitis. Bearing these results in mind may improve quality of endoscopic screening and reduce incidence of PEBN.



Publication History

Received: 15 April 2025

Accepted after revision: 05 January 2026

Accepted Manuscript online:
06 January 2026

Article published online:
22 January 2026

© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Satoko Kako, Yugo Iwaya, Atsuhiro Hirayama, Takuma Okamura, Norikazu Arakura, Tomoaki Suga, Takayuki Watanabe, Akihiro Ito, Daichi Hara, Tadanobu Nagaya. Characteristics and causes of post-endoscopy Barrett’s neoplasia: Retrospective multicenter study. Endosc Int Open 2026; 14: a27816649.
DOI: 10.1055/a-2781-6649
 
  • References

  • 1 Hvid-Jensen F, Pedersen L, Drewes AM. et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383
  • 2 Qumseya B, Sultan S, Bain P. et al. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc 2019; 90: 335-359.e332
  • 3 Shaheen NJ, Falk GW, Iyer PG. et al. Diagnosis and management of Barrett's Esophagus: An updated ACG guideline. Am J Gastroenterol 2022; 117: 559-587
  • 4 Weusten B, Bisschops R, Dinis-Ribeiro M. et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2023; 55: 1124-1146
  • 5 Rodríguez de Santiago E, Hernanz N, Marcos-Prieto HM. et al. Rate of missed oesophageal cancer at routine endoscopy and survival outcomes: A multicentric cohort study. United European Gastroenterol J 2019; 7: 189-198
  • 6 Sawas T, Majzoub AM, Haddad J. et al. Magnitude and time-trend analysis of postendoscopy esophageal adenocarcinoma: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2022; 20: e31-e50
  • 7 Visrodia K, Singh S, Krishnamoorthi R. et al. Magnitude of missed esophageal adenocarcinoma after barrett's esophagus diagnosis: A systematic review and meta-analysis. Gastroenterology 2016; 150: 599-607.e597 quiz e514–595
  • 8 Rutter MD, Beintaris I, Valori R. et al. World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. Gastroenterology 2018; 155: 909-925.e903
  • 9 Desai M, Lieberman D, Srinivasan S. et al. Post-endoscopy Barrett's neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy. Endoscopy 2022; 54: 881-889
  • 10 Kamran U, King D, Abbasi A. et al. A root cause analysis system to establish the most plausible explanation for post-endoscopy upper gastrointestinal cancer. Endoscopy 2023; 55: 109-118
  • 11 Wani S, Williams JL, Komanduri S. et al. Over-utilization of repeat upper endoscopy in patients with non-dysplastic Barrett's esophagus: A Quality Registry study. Am J Gastroenterol 2019; 114: 1256-1264
  • 12 Sharma P, Dent J, Armstrong D. et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
  • 13 Japanese Classification of Esophageal Cancer, 11th Edition: part II and III. Esophagus [Anonym]. 2017; 14: 37-65
  • 14 Amano Y, Ishimura N, Furuta K. et al. Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels?. Gastrointest Endosc 2006; 64: 206-211
  • 15 Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854
  • 16 Kitagawa Y, Ishihara R, Ishikawa H. et al. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2. Esophagus 2023; 20: 373-389
  • 17 Ishihara R, Arima M, Iizuka T. et al. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 2020; 32: 452-493
  • 18 The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc [Anonym]. 2003; 58: S3-43
  • 19 Toyoshima O, Nishizawa T, Koike K. Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis. World J Gastroenterol 2020; 26: 466-477
  • 20 Sugano K, Tack J, Kuipers EJ. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353-1367
  • 21 Schlemper RJ, Riddell RH, Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
  • 22 Schlemper RJ, Kato Y, Stolte M. Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol 2000; 15: G49-G57
  • 23 Katsube T, Adachi K, Furuta K. et al. Difference in localization of esophageal mucosal breaks among grades of esophagitis. J Gastroenterol Hepatol 2006; 21: 1656-1659
  • 24 Edebo A, Vieth M, Tam W. et al. Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus 2007; 20: 232-238
  • 25 Chela HK, Gangu K, Ertugrul H. et al. The 8th wonder of the cancer world: Esophageal cancer and inflammation. Diseases 2022; 10: 44
  • 26 Beydoun AS, Stabenau KA, Altman KW. et al. Cancer risk in Barrett's Esophagus: A clinical review. Int J Mol Sci 2023; 24
  • 27 Gupta N, Gaddam S, Wani SB. et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 2012; 76: 531-538
  • 28 Dhaliwal L, Codipilly DC, Gandhi P. et al. Neoplasia detection rate in Barrett's esophagus and its impact on missed dysplasia: Results from a large population-based database. Clin Gastroenterol Hepatol 2021; 19: 922-929.e921
  • 29 van Putten M, Johnston BT, Murray LJ. et al. “Missed” oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study. United European Gastroenterol J 2018; 6: 519-528
  • 30 Triggs JR, Falk GW. Best practices in surveillance for Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021; 31: 59-75
  • 31 Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92: 586-591
  • 32 Dumoulin FL, Rodriguez-Monaco FD, Ebigbo A. et al. Artificial intelligence in the management of Barrett's esophagus and early esophageal adenocarcinoma. Cancers (Basel) 2022; 14
  • 33 Spadaccini M, Vespa E, Chandrasekar VT. et al. Advanced imaging and artificial intelligence for Barrett's esophagus: What we should and soon will do. World J Gastroenterol 2022; 28: 1113-1122
  • 34 Jukema JB, Kusters CHJ, Jong MR. et al. Computer-aided diagnosis improves characterization of Barrett's neoplasia by general endoscopists. Gastrointest Endosc 2024; 100: 616-625.e8
  • 35 Song YQ, Mao XL, Zhou XB. et al. Use of artificial intelligence to improve the quality control of gastrointestinal endoscopy. Front Med (Lausanne) 2021; 8: 709347
  • 36 Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-1895
  • 37 Iwaya Y, Iijima K, Hikichi T. et al. Evaluating the discrepancies between evidence-based and community standard practices in the endoscopic examination of Barrett's esophagus: a nationwide survey in Japan. Esophagus 2025;
  • 38 Sharma P, Hawes RH, Bansal A. et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut 2013; 62: 15-21
  • 39 Yalamarthi S, Witherspoon P, McCole D. et al. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy 2004; 36: 874-879
  • 40 Goldblum JR. Barrett's esophagus and Barrett's-related dysplasia. Mod Pathol 2003; 16: 316-324